Hypercalcemia
Alerts and Notices
Important News & Links
Synopsis
Drug-induced hypercalcemia can be due to excessive drug consumption (vitamin A, vitamin D, or thiazide diuretics). Calcium absorption (or bone resorption) exceeds the excretion of calcium, resulting in excess calcium in the blood. Less commonly associated medications include lithium (due to increased secretion of parathyroid hormone [PTH]), teriparatide, theophylline (mild toxicity via beta-adrenergic regulation), and certain topical ointments.
Non-drug-induced causes are parathyroid disorders, specific malignancies such as solid tumors (commonly lung, breast, ovarian, kidney, and pancreatic primary tumors), carcinomas with or without bone metastases, hematologic cancers (leukemia, lymphoma, myeloma, etc), granulomatous diseases (sarcoidosis, tuberculosis, granulomatosis with polyangiitis, histoplasmosis, coccidioidomycosis, silicosis, berylliosis, Pneumocystis pneumonia, and Nocardia infection), chronic liver disease, renal insufficiency, kidney transplant, bacteriosis, parenteral feeding, and familial hypocalciuric hypercalcemia.
Cancer-associated hypercalcemia may be caused by elevated levels of PTH, PTH-related protein, 1,25-dihydroxyvitamin D, tumor necrosis factor (TNF), interleukin (IL)-6, IL-1, macrophage inhibitory protein, and other mediators. Cancer-associated hypercalcemia has a poor prognosis.
Rare causes include dehydration, pheochromocytoma, acute adrenal insufficiency, Paget disease, Williams syndrome, and prolonged immobilization.
Codes
E83.52 – Hypercalcemia
SNOMEDCT:
66931009 – Hypercalcemia
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Updated:05/04/2022